Stocks and Investing Stocks and Investing
Thu, March 23, 2023

Raghuram Selvaraju Maintained (SPRB) at Strong Buy with Decreased Target to $10 on, Mar 23rd, 2023


Published on 2024-10-28 02:23:31 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Spruce Biosciences, Inc." (SPRB) at Strong Buy with Decreased Target from $20 to $10 on, Mar 23rd, 2023.

Raghuram has made no other calls on SPRB in the last 4 months.



There are 3 other peers that have a rating on SPRB. Out of the 3 peers that are also analyzing SPRB, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Raghuram


  • Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $8 on, Monday, March 20th, 2023
  • Jonathan Wolleben of "JMP Securities" Maintained at Buy and Held Target at $7 on, Friday, March 17th, 2023
  • Tiago Fauth of "Credit Suisse" Reiterated at Buy and Held Target at $4 on, Friday, March 17th, 2023
Contributing Sources